A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets.
about
Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virusAvian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving targetOne-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge.Evaluation of three live attenuated H2 pandemic influenza vaccine candidates in mice and ferrets.African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates.Mammalian models for the study of H7 virus pathogenesis and transmission.The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccinesRecombinant influenza H7 hemagglutinins induce lower neutralizing antibody titers in mice than do seasonal hemagglutinins.Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets.Immunization with a live attenuated H7N9 influenza vaccine protects mice against lethal challenge.Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza.A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferretsAn adjuvant for the induction of potent, protective humoral responses to an H5N1 influenza virus vaccine with antigen-sparing effect in mice.Classical swine H1N1 influenza viruses confer cross protection from swine-origin 2009 pandemic H1N1 influenza virus infection in mice and ferrets.Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses.Comparison of a live attenuated 2009 H1N1 vaccine with seasonal influenza vaccines against 2009 pandemic H1N1 virus infection in mice and ferrets.Prevention of Influenza A(H7N9) and Bacterial Infections in Mice Using Intranasal Immunization With Live Influenza Vaccine and the Group B Streptococcus Recombinant Polypeptides.Cold-adapted pandemic 2009 H1N1 influenza virus live vaccine elicits cross-reactive immune responses against seasonal and H5 influenza A viruses.Effect of priming with H1N1 influenza viruses of variable antigenic distances on challenge with 2009 pandemic H1N1 virus.Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferretsA broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular headEfficacy of Live-Attenuated H9N2 Influenza Vaccine Candidates Containing NS1 Truncations against H9N2 Avian Influenza VirusesAn H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans.A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys.The magnitude of local immunity in the lungs of mice induced by live attenuated influenza vaccines is determined by local viral replication and induction of cytokinesEvaluation of live attenuated H7N3 and H7N7 vaccine viruses for their receptor binding preferences, immunogenicity in ferrets and cross reactivity to the novel H7N9 virus.A live attenuated vaccine prevents replication and transmission of H7N9 virus in mammals.Induction of protective CD4+ T cell-mediated immunity by a Leishmania peptide delivered in recombinant influenza viruses.The contribution of systemic and pulmonary immune effectors to vaccine-induced protection from H5N1 influenza virus infection.The new temperature-sensitive mutation PA-F35S for developing recombinant avian live attenuated H5N1 influenza vaccine.Pathogenesis, transmissibility, and ocular tropism of a highly pathogenic avian influenza A (H7N3) virus associated with human conjunctivitis.Evaluation of live attenuated influenza a virus h6 vaccines in mice and ferretsAttenuated strains of influenza A viruses do not induce degradation of RNA polymerase II.Baculovirus vector as a delivery vehicle for influenza vaccines.Past, present, and possible future human infection with influenza virus A subtype H7.CHD6, a cellular repressor of influenza virus replication, is degraded in human alveolar epithelial cells and mice lungs during infection.An Adenovirus-Vectored Influenza Vaccine Induces Durable Cross-Protective Hemagglutinin Stalk Antibody Responses in Mice.Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
P2860
Q23921202-DA8B7F0F-F22E-4664-8D30-C9D661D65B2CQ30227194-5786AB47-A0EB-4788-84CB-D72C3B719924Q30355863-C7314C53-F375-48EE-9622-DE5AC3C75412Q30357270-1421958A-0ECB-4906-9C1A-D623D7D14787Q30362332-3F2759E5-E7AC-4168-824E-EF161E17936BQ30364385-8CFCD505-4134-40CD-9E7D-C60F61BD6CDCQ30365696-7053C0F8-76F3-4BCF-A3BE-818D0D464C05Q30366722-6DA5802D-CA16-4F89-9D00-D8616FDA12D1Q30372696-B8560B53-F75F-43E8-828A-5496592DFA6BQ30373843-FB199BE8-8119-4B88-8C7A-99A21411F62BQ30377205-08C57B4A-78F2-49CD-9EE9-FC19DF21172CQ30377443-8CFC6940-EA03-4A0E-92EE-6717C350A009Q30378263-317EFE24-082D-4DE9-AE8C-7CF3ACD1D4FFQ30383905-2111FBBC-F3D6-40AC-9656-BDCF64A99AC6Q30390234-B6A58F9D-0608-4105-92DB-77BACD946D1FQ30394606-C1E78EBC-F497-4DFF-B38B-3DCF31E47696Q30395088-3075446A-751A-4A9B-A4E8-F20FED849044Q30398879-9FA43043-8393-41C2-AD89-ADB53EEAB9F6Q30403077-2F1BC746-105E-479E-B740-6570271F2012Q30414515-3CC93C19-9DAE-4702-8AC2-593E0CEFCE3EQ30417675-30F38230-2FD5-4BCE-8C3C-EE30C77FC6F0Q33743763-B01572C3-DB58-4C20-8E16-F2977A2C403CQ33743865-9D190B85-F365-45E0-A844-3060C45D679AQ33794563-DC51C136-CF96-47EE-BDBC-7C36A3FA24A1Q34057737-762C80D5-2D0B-4B29-A340-5BD823242150Q34295941-3BD4503A-6AA1-4410-BCE3-8E1343329009Q34458066-F86F9600-5F84-4C32-9DED-F2EDBE43FFE0Q35018600-3A6FC351-BCCE-4273-B2AB-442CA2D8A430Q35710438-E678091D-0209-4706-B94B-437D648B0F92Q35845737-0BB37A37-AC99-4AAF-BC49-B846E31527C3Q35943771-05C2146D-EE85-4E2C-8CF9-809FB380ACB8Q36146504-04F71319-F6AA-4095-A2EF-B17602D269B7Q36827443-298F5E0E-C9C0-4921-94DA-BB2EA22BC829Q37033178-976B6AFB-D4CD-4FD1-837C-3F907B213DDEQ37410776-675CA982-5296-4BD8-93B6-F3F23F02562FQ37434539-E4F1C6FC-729C-4ED2-B8C1-E85EB3AB3CD6Q37517921-9D6843A8-B85F-4685-BC01-192B6132007FQ39194807-DE74C84C-5C5A-4115-9C70-06369039646AQ40076766-1C81F921-0961-45E0-AD33-78E8B8BB047EQ40097582-C713583A-7C8E-44C7-AAFC-9AB29FBF1050
P2860
A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A live attenuated cold-adapted ...... 7 viruses in mice and ferrets.
@ast
A live attenuated cold-adapted ...... 7 viruses in mice and ferrets.
@en
type
label
A live attenuated cold-adapted ...... 7 viruses in mice and ferrets.
@ast
A live attenuated cold-adapted ...... 7 viruses in mice and ferrets.
@en
prefLabel
A live attenuated cold-adapted ...... 7 viruses in mice and ferrets.
@ast
A live attenuated cold-adapted ...... 7 viruses in mice and ferrets.
@en
P2093
P2860
P50
P1433
P1476
A live attenuated cold-adapted ...... H7 viruses in mice and ferrets
@en
P2093
Josephine McAuliffe
Leatrice Vogel
Tomy Joseph
P2860
P304
P356
10.1016/J.VIROL.2008.05.021
P407
P577
2008-06-27T00:00:00Z